Wednesday, December 31, 2025 9:39:47 AM
I ask, because you seem to have a better understanding than most here about regulatory issues.
Flipper posted (and I trimmed it down slightly):
1. The "Approvable with Conditions" Trigger
When the CHM (Commission on Human Medicines) finishes its final review of a Marketing Authorization Application (MAA), they rarely just say "Yes." Instead, they often issue a "Positive Advice with Conditions."
• The Conditions: These are "minor" items—changes to the wording of the patient leaflet, final tweaks to the Risk Management Plan (RMP), or small clarifications on the manufacturing (CMC) data for Sawston.
• The Advice Letter: The CHM sends a formal letter to the company (NWBO) stating: "We recommend approval, provided you fix these specific items."
2. The Statutory 28-Day Response Window
Under Schedule 11 of the Human Medicines Regulations 2012, once that (hypothetical) letter arrives, the clock starts:
• The Deadline: The applicant has exactly 28 calendar days to submit their final "clean-up" response.
• The "Clean-Up": During this time, the company's "armies of consultants" (as Linda called them) work around the clock to revise the documents to match the CHM's exact requirements.
• The "Wait": The MHRA "stops the clock" on the MAA while they wait for this response.
3.
The Math: Linking December 19 to January 31
If we apply this 28-day rule to the current (hypothetical) NWBO timeline, the arithmetic is striking:
• Dec 19: (hypothetical) CHM Meeting / Positive Advice with Conditions issued.
• Dec 20 – Jan 16: The 28-Day Clean-Up Window. The company is busy answering those final "cycles of questions."
• Jan 16 (Friday): NWBO submits the final response package to the MHRA.
• Jan 19 – Jan 30: Final MHRA Compliance Check. The MHRA executive staff takes about 10–14 days to verify the response, perform final "Sovereign Network" audits, and prepare the Grant Letter.
• Jan 31 (Friday): (hypothetically) The Grant. The license is issued, the 8-K is filed, and the "Interlopers" make their move.
Why this (hypothetically) explains Linda’s "No Idea" Comment
Because the 28-day window is a statutory right for the company, the MHRA cannot legally issue the final grant until the company submits its response.
• If Linda hasn't hit "Send" on the final response yet, she can technically say she "has no idea" when the final decision will occur, because the ball is still in her court.
• However, by pinning the construction start to the "end of January," she is admitting when she plans to finish that clean-up.
Summary
The 28-day rule is the legal "buffer" that turns a scientific "Yes" into a commercial reality. It allows the company (hypothetically) to fix minor errors without having to re-apply from scratch.
And I hope Flipper also updates his post for us, as well!
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
